Renoprotective impacts of metformin with insulin in type 1 diabetes; role of its antioxidant efficacy

Renoprotective impacts of metformin with insulin in type 1 diabetes; role of its antioxidant efficacy

Bibliographic Details
Main Authors:	Esmaeel Babaeenezhad, Amin Hasanvand
Format:	Article
Language:	English
Published:	Society of Diabetic Nephropathy Prevention 2018-07-01
Series:	Journal of Nephropathology
Subjects:	diabetic kidney diseasetype 2 diabetes insulin diabetic nephropathy type 1 diabetes atherosclerosis
Online Access:	https://nephropathol.com/PDF/jnp-7-217.pdf

Similar Items

Metformin with insulin relieves oxidative stress and confers renoprotection in type 1 diabetes in vivo
by: Christine Driver, et al.
Published: (2018-07-01)

New perspectives of renoprotection in patients with Type 2 diabetes mellitus and arterial hypertension
by: A. S. Ametov, et al.
Published: (2004-12-01)

Renoprotective Effects of DPP-4 Inhibitors
by: Daiji Kawanami, et al.
Published: (2021-02-01)

Comparing the renoprotective effects of the antioxidants melatonin, vitamin D and vitamin E in diabetic rats
by: Abdulmonim A. Alqasim, Ph.D, et al.
Published: (2020-10-01)

The Association Between Insulin Resistance, Leptin, and Resistin and Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients with Different Body Mass Indexes
by: Huang J, et al.
Published: (2021-05-01)

Significance of Metformin Use in Diabetic Kidney Disease
by: Daiji Kawanami, et al.
Published: (2020-06-01)

Esculetin ameliorates insulin resistance and type 2 diabetic nephropathy through reversal of histone H3 acetylation and H2A lysine 119 monoubiquitination
by: Almesh Kadakol, et al.
Published: (2017-08-01)

The Nicotinamide/Streptozotocin Rodent Model of Type 2 Diabetes: Renal Pathophysiology and Redox Imbalance Features
by: Liang-Jun Yan
Published: (2022-09-01)

Metformin attenuates streptozotocin-induced diabetic nephropathy in rats through activation of AMPK signaling pathway
by: Amin Hasanvand, et al.
Published: (2018-01-01)

Cardiovascular risk in type 1 diabetes mellitus
by: Ines Ben Hadj Slama Slim
Published: (2013-01-01)

Relationship between insulin treatment and diabetic retinopathy in patients with type 2 diabetes mellitus
by: Jiao Su, et al.
Published: (2019-03-01)

Association of serum Sestrin-2 level with insulin resistance, metabolic syndrome, and diabetic nephropathy in patients with type 2 diabetes
by: Hazem M EL-Ashmawy, et al.
Published: (2019-01-01)

Acarbose Reduces Low-Grade Albuminuria Compared to Metformin in Chinese Patients with Newly Diagnosed Type 2 Diabetes
by: Song L, et al.
Published: (2021-11-01)

A retrospective cohort study of clinical characteristics and outcomes of type 2 diabetic patients with kidney disease
by: Xi He, et al.
Published: (2024-02-01)

The use of metformin as an add-on therapy to insulin in the treatment of poorly controlled type 1 diabetes mellitus in adolescents
by: Katsiaryna Sikorskaya, BSN, RN, CSN, et al.
Published: (2021-03-01)

The Role of Autophagy in Type 2 Diabetic Kidney Disease Management
by: Che-Hao Tseng, et al.
Published: (2023-11-01)

Prevalence and characteristics of diabetic kidney disease in type 2 diabetic patients in Abidjan, Côte d’Ivoire
by: Sindou Sanogo, et al.
Published: (2018-05-01)

Evaluation of changes in glycemic control and diabetic complications over time and factors associated with the progression of diabetic complications in Japanese patients with juvenile‐onset type 1 diabetes mellitus
by: Takafumi Masuda, et al.
Published: (2024-02-01)

Kidney Biopsy in Type 2 Diabetic Patients: Critical Reflections on Present Indications and Diagnostic Alternatives
by: Domenico Santoro, et al.
Published: (2021-05-01)

Fetuin-A level in type 2 diabetic patients: relation to microvascular complications
by: Nehal H Al-Said, et al.
Published: (2018-01-01)

Morphological pattern of non-diabetic nephropathy in type 2 diabetes mellitus patients
by: Meral Mese, et al.
Published: (2022-06-01)

Effects of Smoking on Diabetic Nephropathy
by: Yasemin Gündoğdu, et al.
Published: (2022-02-01)

The Frequency of Diabetic Nephropathy in Children and Adolescents with Type 1 Diabetes Mellitus
by: Neda Mostofizadeh, et al.
Published: (2019-09-01)

Comparative analysis of glycemic control effectiveness and microvascular complications in patients with type 1 diabetes mellitus, treated with genetically engineered human insulin or human insulin analogues: A 10-year retrospective observational study
by: Marina V. Shestakova, et al.
Published: (2016-11-01)

Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?
by: Dzięgielewska-Gęsiak S, et al.
Published: (2022-11-01)

Efficacy of metformin and insulin in the management of gestational diabetes mellitus: A comparative study
by: Anupama Marnal B. A, et al.
Published: (2023-07-01)

Late Diabetic Complications in Patients with Type 1 Diabetes who Received Simultaneous Pancreas-Kidney Transplantation
by: Alexandra Michailovna Glazunova, et al.
Published: (2015-06-01)

Diabetic Kidney Disease in Post-Kidney Transplant Patients
by: Ngoc-Yen T. Pham, et al.
Published: (2024-01-01)

Plasma copeptin level in type 2 diabetic patients and its role in diabetic nephropathy
by: Nevein Nabil El-Soudany, et al.
Published: (2023-04-01)

Evaluation of Subclinical Vascular Disease in Diabetic Kidney Disease: A Tool for Personalization of Management of a High-Risk Population
by: Christodoula Kourtidou, et al.
Published: (2022-07-01)

Study of phases of insulin secretion in pre-diabetes and newly diagnosed type 2 diabetes mellitus
by: Sabreena Mohtarin, et al.
Published: (2016-07-01)

Metformin improves diabetic kidney disease
by: Beladi Mousavi Seyed Seifollah, et al.
Published: (2012-01-01)

Association of single nucleotide polymorphisms with insulin secretion, insulin sensitivity, and diabetes in women with a history of gestational diabetes mellitus
by: Rashmi B. Prasad, et al.
Published: (2021-11-01)

Ameliorative effects of histidine on oxidative stress, tumor necrosis factor alpha (TNF-α), and renal histological alterations in streptozotocin/nicotinamide-induced type 2 diabetic rats
by: Maryam Nasri, et al.
Published: (2020-06-01)

Antidiabetic and Other Therapies Used in Subjects with Diabetes and Chronic Kidney Disease in a Hospital-Based Clinic Population in Greece
by: Ilias N. Migdalis, et al.
Published: (2021-05-01)

Potential Role of Copper in Diabetes and Diabetic Kidney Disease
by: Guido Gembillo, et al.
Published: (2022-12-01)

Angiotensin II type 1 receptor gene polymorphism could influence renoprotective response to losartan treatment in type 1 diabetic patients with high urinary albumin excretion rate
by: Dragović Tamara, et al.
Published: (2010-01-01)

Proliferative diabetic retinopathy is associated with microalbuminuria in patients with type 2 diabetes
by: M.C. Boelter, et al.
Published: (2006-08-01)

Type 2 diabetes - factors of occurrence and its complications
by: Magda Żuchnik, et al.
Published: (2023-03-01)

Development of Microvascular Complications in Type 1 Diabetic Patients 10 Years Follow-up
by: Indira Kulenović, et al.
Published: (2006-05-01)